Juvenescence Ltd - 03 Feb 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
10%+ Owner
Signature
/s/ Gregory Bailey, CEO
Issuer symbol
SER
Transactions as of
03 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:42:29 UTC
Next filing
11 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Purchase $0 +308,565 $0.000000 308,565 03 Feb 2022 Common Stock 308,565 $0.8102 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under a Secured Convertible Facility Agreement between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.